132 related articles for article (PubMed ID: 17975142)
1. Expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in neuroblastoma: correlation with clinical features, cellular localization, and cerulenin-mediated apoptosis regulation.
Geerts D; Wallick CJ; Koomoa DL; Koster J; Versteeg R; Go RC; Bachmann AS
Clin Cancer Res; 2007 Nov; 13(21):6312-9. PubMed ID: 17975142
[TBL] [Abstract][Full Text] [Related]
2. Subcellular distribution and expression of prenylated Rab acceptor 1 domain family, member 2 (PRAF2) in malignant glioma: Influence on cell survival and migration.
Borsics T; Lundberg E; Geerts D; Koomoa DL; Koster J; Wester K; Bachmann AS
Cancer Sci; 2010 Jul; 101(7):1624-31. PubMed ID: 20412121
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of PRAF2 in the human brain and enrichment in synaptic vesicles.
Koomoa DL; Go RC; Wester K; Bachmann AS
Neurosci Lett; 2008 May; 436(2):171-6. PubMed ID: 18395978
[TBL] [Abstract][Full Text] [Related]
4. PRAF2 stimulates cell proliferation and migration and predicts poor prognosis in neuroblastoma.
Yco LP; Geerts D; Koster J; Bachmann AS
Int J Oncol; 2013 Apr; 42(4):1408-16. PubMed ID: 23440329
[TBL] [Abstract][Full Text] [Related]
5. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
7. Genomic organization, expression profile, and characterization of the new protein PRA1 domain family, member 2 (PRAF2).
Fo CS; Coleman CS; Wallick CJ; Vine AL; Bachmann AS
Gene; 2006 Apr; 371(1):154-65. PubMed ID: 16481131
[TBL] [Abstract][Full Text] [Related]
8. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
9. The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome.
Oberthuer A; Hero B; Spitz R; Berthold F; Fischer M
Clin Cancer Res; 2004 Jul; 10(13):4307-13. PubMed ID: 15240516
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase expression in human neuroblastoma: immunohistochemical and real-time PCR analyses.
Beierle EA; Massoll NA; Hartwich J; Kurenova EV; Golubovskaya VM; Cance WG; McGrady P; London WB
Clin Cancer Res; 2008 Jun; 14(11):3299-305. PubMed ID: 18519756
[TBL] [Abstract][Full Text] [Related]
12. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
13. Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma.
Nowacki S; Skowron M; Oberthuer A; Fagin A; Voth H; Brors B; Westermann F; Eggert A; Hero B; Berthold F; Fischer M
Oncogene; 2008 May; 27(23):3329-38. PubMed ID: 18084322
[TBL] [Abstract][Full Text] [Related]
14. Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory.
Albino D; Scaruffi P; Moretti S; Coco S; Truini M; Di Cristofano C; Cavazzana A; Stigliani S; Bonassi S; Tonini GP
Cancer; 2008 Sep; 113(6):1412-22. PubMed ID: 18671248
[TBL] [Abstract][Full Text] [Related]
15. Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression.
Ngan ES; Sit FY; Lee K; Miao X; Yuan Z; Wang W; Nicholls JM; Wong KK; Garcia-Barcelo M; Lui VC; Tam PK
Clin Cancer Res; 2007 Feb; 13(3):868-75. PubMed ID: 17289879
[TBL] [Abstract][Full Text] [Related]
16. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
[TBL] [Abstract][Full Text] [Related]
17. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
[TBL] [Abstract][Full Text] [Related]
18. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors.
Martin DT; Gendron RL; Jarzembowski JA; Perry A; Collins MH; Pushpanathan C; Miskiewicz E; Castle VP; Paradis H
Clin Cancer Res; 2007 Mar; 13(5):1480-7. PubMed ID: 17332292
[TBL] [Abstract][Full Text] [Related]
19. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA
Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
